Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
300
-
Total 13F shares, excl. options
-
77.5M
-
Shares change
-
-125K
-
Total reported value, excl. options
-
$9B
-
Value change
-
-$79.6M
-
Put/Call ratio
-
1.57
-
Number of buys
-
134
-
Number of sells
-
-189
-
Price
-
$116.17
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q3 2021
419 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q3 2021.
NovoCure Ltd - Common Stock (NVCR) has 300 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 77.5M shares
of 112M outstanding shares and own 69.18% of the company stock.
Largest 10 shareholders include Capital World Investors (12.6M shares), Capital International Investors (10.6M shares), BAILLIE GIFFORD & CO (9.37M shares), FMR LLC (8.27M shares), VANGUARD GROUP INC (7.86M shares), BlackRock Inc. (6.72M shares), STATE STREET CORP (2.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.43M shares), CREDIT SUISSE AG/ (1.38M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.23M shares).
This table shows the top 300 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.